A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
Condition: Post Operative Pain Interventions: Drug: F14; Drug: 0.25 % Bupivacaine HCl; Drug: Acetaminophen; Drug: Methocarbamol Sponsors: Arthritis Innovation Corporation; Allucent Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials
Methocarbamol in Ventral and Inguinal HR
Conditions: Ventral Hernia; Inguinal Hernia Interventions: Drug: Methocarbamol; Drug: Standard Opioid; Drug: Standard opioid plus methocarbamol Sponsor: Prisma Health-Upstate Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials